BiotechTube
Home/GliaPharm/Dr. Charles Finsterwald, PhD
DC

Dr. Charles Finsterwald, PhD

Leadership Team

GliaPharm

Therapeutic Areas

Alzheimer's DiseaseEpilepsyAmyotrophic Lateral Sclerosis (ALS)Neurological Disorders

GliaPharm Pipeline

DrugIndicationPhase
Lead Program (undisclosed)Alzheimer's DiseasePreclinical
Epilepsy ProgramGLUT1 Deficiency Syndrome (Epilepsy)Preclinical
ALS ResearchAmyotrophic Lateral SclerosisResearch

Leadership Team at GliaPharm

LB
Leon Bushara
Executive Chairman
PP
Prof. Pierre J. Magistretti, MD, PhD
Scientific Founder, Chairman of the Scientific Advisory Board
DS
Dr. Sylvain Lengacher, PhD
Leadership Team
AM
Ambroise Magistretti
Leadership Team
DF
Dr. Francois Jenck, PhD
Leadership Team
DU
Dr. Uwe Meya, MD
Leadership Team
View full GliaPharm profile